Medtronic is 15% equity veeko giant huaxin test water

Last year, the multinational medical device company introduced into China's first single acquisition finally completed.

December 19, the United States Medtronic company and weigao medical polymer products co., Ltd. announced that Medtronic on weigao group equity investment has been completed, Medtronic company for 15% of the shares of the latter, to become its second largest shareholder.

According to the previously announced Medtronic on Granville high equity investment terms, this pile of equity investments, Medtronic spent 17.26 billion (-2.21 million).

This includes, for each unit 11.138 buy viagra high in the Hong Kong stock exchange a new issue of 80,721,081 h share and per share 10.247 buy viagra high existing shareholders hold the same number of unissued shares.

At the same time, the parties will establish a joint venture in China for exclusive distribution Medtronic company and veeko orthopaedic company of orthopaedic products.

The joint venture between 51% and 49%.

"This is our increase in China's important milestones.

"Medtronic global Chairman and CEO Bill · Hawkins said.

Medtronic company was founded in 1949, cardiac pacemakers and other heart disease medical equipment manufacturing, sales and marketing.

Fiscal year 2006 global sales of $ 113 billion. Veeko mainly in China engaged in research, production and sale of single-use medical devices.

In fact, Medtronic is not the first House and China medical device supplier cooperation of the Giants, but to joint ventures and equity approach, in the country for the first time.

This also means that multinational medical giants in China's development, a more radical and the initiative started.

For multinational corporations, local companies in the country for many years of sales experience and unique sales channels and an extensive customer base is the largest attraction points.

Combined with local enterprises, expansion of the domestic market for standard products is in line with future medical giants – the focus of China's urban community and rural Foundation medical market.

Under the medical device industry, "" eleventh five-year development plan ", the Government in health care will spend USD 217 billion yuan, of which 68 billion will be used to purchase medical equipment.

Industry-wide forecasting, small and medium-sized hospitals for low-cost medical equipment demand will grow substantially.

Medtronic has also told reporters that want the company's products in the future you can override the low-end market, are more capable of "price".

Medtronic said they hope that in the next 5 to 10 years, the income from the Chinese market will exceed 5%.